Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CRHR1 | P34998 | 3/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | PKM | P14618 | 1/20 | 0.34 |
| ▸ | NOS3 | P29474 | 1/20 | 0.31 |
| ▸ | NOS1 | P29475 | 1/20 | 0.31 |
| ▸ | NOS2 | P35228 | 1/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23772047 | 0.74 | MEN1 (0.31) | — | |
| SCHEMBL26569679 | 0.74 | KDM4E (0.39) | KDM4EPKMCYP2C9CYP2C19NPSR1 | |
| SCHEMBL14726084 | 0.70 | NUDT1 (0.32) | NOS3NOS1NOS2 | |
| SCHEMBL12622272 | 0.69 | CRHR1 (0.42) | CRHR1KDM4EPKMNOS3NOS1 | |
| SCHEMBL13531387 | 0.69 | PSMB5 (0.38) | CRHR1KDM4EPKMNOS3NOS1 | |
| SCHEMBL21341302 | 0.69 | NUDT1 (0.32) | — | |
| SCHEMBL21341719 | 0.68 | POLB (0.35) | — | |
| SCHEMBL12169342 | 0.68 | NOS3 (0.50) | KDM4ENOS3NOS1NOS2 | |
| SCHEMBL21719363 | 0.67 | NUDT1 (0.31) | — | |
| SCHEMBL4569226 | 0.67 | NUDT1 (0.50) | KDM4ENOS3NOS1NOS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230337517-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2023-10-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230337517-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | LBR, OCIAD2, OCIAD1 | CRHR1 1709/4885KDM4E 3832/4885PKM 2937/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.